(Q37408456)

20 August 2017

Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women (English)

1 reference

20 August 2017

1 reference

1 reference

1

Dawn L Hershman

1 reference

20 August 2017

5

Alfred I Neugut

1 reference

20 August 2017

Donna Buono

2

1 reference

20 August 2017

Russell B McBride

series ordinal

3

1 reference

20 August 2017

Wei Yann Tsai

series ordinal

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

20 August 2017

1 reference

20 August 2017

115

1 reference

20 August 2017

17

1 reference

20 August 2017

3848-3857

1 reference

The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Effectiveness of adjuvant chemotherapy for node-positive operable breast cancer in older women

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Breast cancer treatment in clinical practice compared to best evidence and practice guidelines

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Utility of the SEER-Medicare data to identify chemotherapy use.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Development of a comorbidity index using physician claims data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Why do physicians vary so widely in their referral rates?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Models for longitudinal data: a generalized estimating equation approach

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

NCCN Breast Cancer Practice Guidelines. The National Comprehensive Cancer Network

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Physician reimbursement by salary or fee-for-service: effect on physician practice behavior in a randomized prospective study.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Properties of analysis methods that account for clustering in volume-outcome studies when the primary predictor is cluster size

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Do oncologists believe new cancer drugs offer good value?

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Older women with breast carcinoma are less likely to receive adjuvant chemotherapy: evidence of possible age bias?

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Drug sales bring huge profits, and scrutiny, to cancer doctors: insurers and experts see high costs and conflicts.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Impact of referral patterns on the use of chemotherapy for lung cancer.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

The effects of payment method on clinical decision-making: physician responses to clinical scenarios

2 September 2018

1 reference

12 December 2020

Consensus conference. Adjuvant chemotherapy for breast cancer

1 reference

12 December 2020

Assessing illness severity: does clinical judgment work?

1 reference

12 December 2020

NIH consensus conference. Treatment of early-stage breast cancer

1 reference

12 December 2020

Physician response to patient insurance status in ambulatory care clinical decision-making. Implications for quality of care

1 reference

12 December 2020

Physicians' reasons for failing to deliver effective breast cancer care: a framework for underuse

1 reference

12 December 2020

Use and Outcomes of Adjuvant Chemotherapy in Older Women With Breast Cancer

1 reference

12 December 2020

Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.24448

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

19517470

1 reference